Loading clinical trials...
Loading clinical trials...
Phase 1, Open Label, Randomized, Single-center, 2-sequence, 2-period, 2 Treatment Single Dose Crossover Bioequivalence Study Comparing Venglustat Tablet Formulation (Test) to Hard Capsule Formulation (Reference)
Conditions
Interventions
Venglustat
Venglustat
Locations
2
United States
Clinical Pharmacology of Miami Site Number : 8400001
Miami, Florida, United States
Prism Research Site Number : 8400002
Saint Paul, Minnesota, United States
Start Date
June 23, 2020
Primary Completion Date
July 13, 2020
Completion Date
July 13, 2020
Last Updated
May 17, 2024
NCT00104325
NCT01399385
NCT05774834
NCT07310264
NCT06904807
NCT06342713
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions